Jay K. Staas
16Patents
10h-index
16Co-inventors
69Inventor score
Filing activity: Mar 18, 1988 → Aug 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5075109A | Method of potentiating an immune response | Emerging Cross-Sectional Technologies | 413 | Expired |
| US5820883A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 182 | Expired |
| US5942252A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 158 | Expired |
| US5853763A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release | Emerging Cross-Sectional Technologies | 150 | Expired |
| US5814344A | Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 143 | Expired |
| US5811128A | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor | Emerging Cross-Sectional Technologies | 112 | Expired |
| US6306425A | Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol | Human Necessities | 56 | Expired |
| US6495155B1 | Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances | Human Necessities | 51 | Expired |
| US6024983A | Composition for delivering bioactive agents for immune response and its preparation | Emerging Cross-Sectional Technologies | 31 | Expired |
| US6312731A | Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6264991A | Compositions and methods for treating intracellular infections | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7473431B2 | Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances | Human Necessities | 5 | Expired |
| US8541028B2 | Methods for manufacturing delivery devices and devices thereof | Human Necessities | 4 | Active |
| US9345911B2 | Methods of inducing melanogenesis in a subject | Human Necessities | 2 | Active |
| US10076555B2 | Methods of inducing melanogenesis in a subject | Human Necessities | 1 | Active |
| US10857208B2 | Methods of inducing melanogenesis in a subject | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.